跳至主要内容
临床试验/NCT02357706
NCT02357706已完成不适用

Comparison of Auto-Adjusting Positive Airway Pressure Devices

ResMed1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2015年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20
试验地点
1
主要终点
Mean Oxygen Desaturation Index (ODI)

研究概览

简要总结

Little is understood about how different auto-adjusting PAP devices operate. The purpose of this evaluation is to compare two devices in a randomised two night PSG trial.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者
否

入选标准

  • •Males aged ≥ 18 years
  • •Recently diagnosed with OSA (AHI ≥15). Recently defined as less than 3 months before study entry
  • •Naive to CPAP therapy
  • •Participants willing and able to give written informed consent

排除标准

  • •Participants requiring Bi-level PAP
  • •Participants requiring supplemental oxygen
  • •Participants who are pregnant
  • •Subjects who have a pre existing lung disease/ condition that would predispose them to pneumothorax (for example: COPD, lung cancer; fibrosis of the lungs; recent (< 2years) case of pneumonia or lung infection; lung injury)

研究组 & 干预措施

Group 1

Active Comparator

Patients will be randomised to either Group 1 or Group 2. Patients in this group (group 1) will use APAP A on the first night of the evaluation, and APAP B on the second night.

干预措施: APAP A (ResMed AirSense AutoSet) (Device)

Group 1

Active Comparator

Patients will be randomised to either Group 1 or Group 2. Patients in this group (group 1) will use APAP A on the first night of the evaluation, and APAP B on the second night.

干预措施: APAP B (Apex iCH Auto) (Device)

Group 2

Active Comparator

Patients will be randomised to either Group 1 or Group 2. Patients in this group (group 2) will use APAP B on the first night of the evaluation and APAP A on the second night.

干预措施: APAP A (ResMed AirSense AutoSet) (Device)

Group 2

Active Comparator

Patients will be randomised to either Group 1 or Group 2. Patients in this group (group 2) will use APAP B on the first night of the evaluation and APAP A on the second night.

干预措施: APAP B (Apex iCH Auto) (Device)

结局指标

主要结局

Mean Oxygen Desaturation Index (ODI)

时间窗: 1 night (446 minutes) for APAP A, 1 night (436 minutes) for APAP B.

Number of times that Oxygen Level Drops by 3% below baseline value, Events/hour

Mean Apnoea-Hypopnoea-Index (AHI)

时间窗: 1 night (446 minutes) for APAP A (AirSense), 1 night (436 minutes) for APAP B (Apex)

AHI measures the number of apnoeas + hypopnoeas per hours of night (events/hour).

次要结局

  • Hypopnoea-Index HI(1 night (446 minutes) for APAP A; 1 night (436 minutes) for APAP B)
  • Flow Limitation (%)(1 night (446 minutes) for APAP A; 1 night (436 minutes) for APAP B)
  • Obstructive Apnoea Index (OAI)(1 night (446 minutes) for APAP A; 1 night (436 minutes) for APAP B)
  • Central Apnoea Index (CAI)(1 night (446 minutes) for APAP A; 1 night (436 minutes) for APAP B)
  • Respiratory Effort Related Arousals RERAs(1 night (446 minutes) for APAP A; 1 night (436 minutes) for APAP B)
  • Mixed Apnoea Index (MAI)(1 night (446 minutes) for APAP A; 1 night (436 minutes) for APAP B)
  • Mean O2 Saturation(1 night (446 minutes) for APAP A; 1 night (436 minutes) for APAP B)

研究者

发起方
ResMed
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验